A detailed history of Northwest & Ethical Investments L.P. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 318,819 shares of GILD stock, worth $39.6 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
318,819
Previous 278,251 14.58%
Holding current value
$39.6 Million
Previous $30.8 Billion 14.73%
% of portfolio
0.83%
Previous 0.77%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$108.22 - $120.47 $4.39 Million - $4.89 Million
40,568 Added 14.58%
318,819 $35.4 Billion
Q2 2025

Aug 12, 2025

SELL
$96.91 - $113.0 $636,117 - $741,732
-6,564 Reduced 2.3%
278,251 $30.8 Billion
Q1 2025

May 13, 2025

BUY
$89.14 - $117.41 $3.62 Million - $4.77 Million
40,620 Added 16.63%
284,815 $31.9 Billion
Q4 2024

Feb 11, 2025

BUY
$83.95 - $97.9 $807,850 - $942,091
9,623 Added 4.1%
244,195 $22.6 Billion
Q3 2024

Nov 13, 2024

BUY
$66.59 - $83.99 $2.11 Million - $2.67 Million
31,746 Added 15.65%
234,572 $19.7 Billion
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $12.8 Million - $14.8 Million
202,826 New
202,826 $13.9 Billion
Q1 2024

Jul 09, 2025

SELL
$71.58 - $87.29 $5.83 Million - $7.11 Million
-81,454 Reduced 28.6%
203,361 $14.9 Billion
Q4 2023

Jul 09, 2025

BUY
$73.27 - $83.09 $449,804 - $510,089
6,139 Added 2.64%
238,987 $19.4 Billion
Q3 2023

Jul 09, 2025

BUY
$73.94 - $80.67 $3.45 Million - $3.76 Million
46,611 Added 25.03%
232,848 $17.4 Billion
Q2 2023

Jul 09, 2025

SELL
$76.01 - $86.7 $257,749 - $293,999
-3,391 Reduced 1.79%
186,237 $14.4 Billion
Q1 2023

Jul 09, 2025

BUY
$77.31 - $88.08 $9.75 Million - $11.1 Million
126,173 Added 198.84%
189,628 $15.7 Billion
Q4 2022

Jul 09, 2025

BUY
$62.32 - $89.47 $1.49 Million - $2.14 Million
23,902 Added 60.43%
63,455 $5.45 Billion
Q3 2022

Jul 09, 2025

SELL
$59.54 - $68.01 $64,600 - $73,790
-1,085 Reduced 2.67%
39,553 $2.44 Billion
Q2 2022

Jul 09, 2025

SELL
$57.72 - $65.01 $14.1 Million - $15.9 Million
-244,177 Reduced 85.73%
40,638 $2.51 Billion
Q3 2020

Jul 08, 2025

BUY
$62.1 - $78.08 $1.44 Million - $1.82 Million
23,264 Added 145.97%
39,202 $2.48 Billion
Q4 2019

Jul 08, 2025

SELL
$61.62 - $67.78 $2.31 Million - $2.54 Million
-37,439 Reduced 70.14%
15,938 $1.04 Billion
Q3 2019

Jul 08, 2025

SELL
$62.51 - $69.0 $2.42 Million - $2.67 Million
-38,690 Reduced 42.02%
53,377 $3.38 Billion
Q2 2019

Jul 08, 2025

BUY
$61.87 - $69.38 $155,293 - $174,143
2,510 Added 2.8%
92,067 $6.22 Billion
Q1 2019

Jul 08, 2025

SELL
$62.53 - $70.05 $315,776 - $353,752
-5,050 Reduced 5.34%
89,557 $5.82 Billion
Q4 2018

Jul 08, 2025

SELL
$60.54 - $79.0 $11.5 Million - $15 Million
-190,208 Reduced 66.78%
94,607 $5.92 Billion
Q3 2018

Jul 08, 2025

BUY
$71.28 - $78.92 $472,586 - $523,239
6,630 Added 14.46%
52,492 $4.05 Billion
Q2 2018

Jul 08, 2025

SELL
$64.88 - $75.68 $3.14 Million - $3.66 Million
-48,371 Reduced 51.33%
45,862 $3.25 Billion
Q1 2018

Jul 08, 2025

BUY
$72.84 - $88.8 $3.74 Million - $4.55 Million
51,281 Added 119.39%
94,233 $7.1 Billion
Q4 2017

Jul 08, 2025

SELL
$71.15 - $83.52 $204,912 - $240,537
-2,880 Reduced 6.28%
42,952 $3.08 Billion
Q3 2017

Jul 08, 2025

SELL
$72.11 - $85.47 $1.77 Million - $2.1 Million
-24,574 Reduced 34.9%
45,832 $3.71 Billion
Q2 2017

Jul 08, 2025

BUY
N/A
2,467 Added 3.63%
70,406 $4.98 Billion
Q1 2017

Jul 08, 2025

SELL
N/A
-21,309 Reduced 23.88%
67,939 $4.61 Billion
Q4 2016

Jul 08, 2025

SELL
N/A
-19,193 Reduced 17.7%
89,248 $6.39 Billion
Q3 2016

Jul 08, 2025

SELL
N/A
-176,374 Reduced 61.93%
108,441 $8.58 Billion
Q2 2015

Jul 08, 2025

BUY
N/A
7,700 Added 31.95%
31,800 $3.72 Billion
Q1 2015

Jul 08, 2025

BUY
N/A
9,700 Added 67.36%
24,100 $2.36 Billion
Q4 2014

Jul 08, 2025

BUY
N/A
14,400 New
14,400 $1.36 Billion
Q2 2014

Jul 08, 2025

SELL
N/A
-32,900 Closed
0 $0
Q4 2013

Jul 08, 2025

SELL
N/A
-251,915
32,900 $2.47 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $156B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Northwest & Ethical Investments L.P. Portfolio

Follow Northwest & Ethical Investments L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest & Ethical Investments L.P., based on Form 13F filings with the SEC.

News

Stay updated on Northwest & Ethical Investments L.P. with notifications on news.